Prevalence of antibiotic-resistant Acinetobacter baumannii in a 1000-bed tertiary care hospital in Tehran, Iran

Indian Journal of Pathology and Microbiology

Volumn 53, Issue 2, 2010, Pages 290-293

  Rahbar, Mohammad ^a   Mehrgan, Hadi ^b   Aliakbari, Negar Haji ^b  

^a MINISTRY OF HEALTH AND MEDICAL EDUCATION   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Acinetobacter baumannii; drug resistance; imipenem; nosocomial infection

Indexed keywords

AMIKACIN; ANTIBIOTIC AGENT; AZTREONAM; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CIPROFLOXACIN; COTRIMOXAZOLE; GENTAMICIN; IMIPENEM; OFLOXACIN; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; TIMENTIN; TOBRAMYCIN;

ACINETOBACTER BAUMANNII; ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; DRUG EFFICACY; FEMALE; HUMAN; IRAN; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PREVALENCE; RESPIRATORY SYSTEM; TERTIARY HEALTH CARE;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ADULT; AGED; ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, BACTERIAL; FEMALE; HOSPITALS; HUMANS; IRAN; MALE; MIDDLE AGED; PREVALENCE; RISK FACTORS;

EID: 77953923822     PISSN: 03774929     EISSN: 09745130     Source Type: Journal    
DOI: 10.4103/0377-4929.64333     Document Type: Article

References (17)

1. Hall GS. Non-fermenting and miscellaneous gram-negative bacilli. In: Mahon CR, Lehman DC, Manuselis G, editors. Textbook of Diagnostic Microbiology. 3rd ed. Philadelphia: WB Saunders; 2007. p. 564-585
2. Montefour K, Frieden J, Hurst S, Helmich C, Headley D, Martin M, Boyle DA. Acinetobacter baumannii: An emerging multidrug-resistant pathogen in critical care. Crit Care Nurse 2008;28:15-25.
3. Fournier PE, Richet H. The epidemiology and control of Acinetobacter baumannii in health care facilities. Clin Infect Dis 2006;42:692-699
4. Richet H, Fournier PE. Nosocomial infections caused by Acinetobacter baumannii: A major threat worldwide. Infect Control Hosp Epidemiol 2006;27:645-646
5. Abbassi M, Rahbar M, Hekmat Yazdi S, Rashed Marandi F, Sabourian R, Saremi M. Evaluation of the 10th External Quality Assessment Scheme results in clinical microbiology laboratories in Tehran and districts. East Mediter Health J 2006;12:310-315
6. Forbes BA, Sahm DF, Weissfeld AS, editors. Bailey and Scott's Diagnostic Microbiology, 10th ed. St. Louis: MO, Mosby; 1998.
7. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing. Fourteenth informational supplement. Document M100-S14. Wayne, PA: NCCLS, 2004.
8. Rahbar M, Hajia M. Detection and quantitation of the etiologic agents of ventilator-associated pneumonia in endotracheal tube aspirates from patients in Iran. Infect Control Hosp Epidemiol 2006;27:884-885
9. Mahgoub S, Ahmed J, Glatt AE. Completely resistant Acinetobacter baumannii strains. Infect Control Hosp Epidemiol 2002;23:477-479
10. Al-Tawfiq JA, Mohandhas TX. Prevalence of antimicrobial resistance in Acinetobacter calcoaceticus-baumannii complex in a Saudi Arabian hospital. Infect Control Hosp Epidemiol 2007;28:870-872
11. Gootz TD, Marra A. Acinetobacter baumannii: an emerging multidrugresistant threat. Expert Rev Anti Infect Ther 2008;6:309-325
12. Perez F, Endimiani A, Bonomo RA. Why are we afraid of Acinetobacter baumannii? Expert Rev Anti Infect Ther 2008;6:269-271
13. Feizabadi MM, Fathollahzadeh B, Taherikalani M, Rasoolinejad M, Sadeghifard N, Aligholi M, Soroush S, Mohammadi-Yegane S. Antimicrobial susceptibility patterns and distribution of blaOXA genes among Acinetobacter spp. isolated from patients at Tehran hospitals. Jpn J Infect Dis 2008;61:274-278
14. Ishii Y, Alba J, Kimura S, Yamaguchi K. Evaluation of antimicrobial activity of beta-lactam antibiotics by E-test against clinical isolates from 100 medical centers in Japan (2004). Diagn Microbiol Infect Dis 2006;55:143-148
15. Karsligil T, Balci I, Zer Y. Antibacterial sensitivity of Acinetobacter strains isolated from nosocomial infections. J Int Med Res 2004;32:436-441
16. Baran G, Erbay A, Bodur H, Ongürü P, Akinci E, Balaban N, Cevik MA. Risk factors for nosocomial imipenem-resistant Acinetobacter baumannii infections. Int J Infect Dis 2008;12:16-21.
17. Cisneros JM, Rodríguez-Baño J, Fernández-Cuenca F, Ribera A, Vila J, Pascual A, et al. Risk-factors for the acquisition of imipenem-resistant Acinetobacter baumannii in Spain: A nationwide study. Clin Microbiol Infect 2005;11:874-879